Therapeutic formulations containing venom or venom anti-serum either alone or in combination for the therapeutic prophylaxis and therapy of neoplasms
OwnerElizabeth SHANAHAN-PRENDERGASTinventor
Life of this patent
Estimating the term…
Abstract
A method of treating a mammal prophylactically to prevent neoplastic development comprises administering to the mammal a therapeutic vaccine comprising venom and at least one adjuvant. The method optionally further comprises administering to the mammal at least one other therapeutically effective agent, e.g., an anti-inflammatory agent.
Claims47
A method of treating neoplasm in a mammal in need of such treatment, comprising administering to said mammal a therapeutic agent comprising venom and/or mammalian, plant or insect anti-serum to venom.
A method according to claim 54 wherein the Phospholipase A2 enzyme is Type I, Type II, Type III or Type IV, and/or the anti-serum to Phospholipase A2 enzyme is anti-serum to Type I, Type II, Type III or Type IV Phospholipase A2 enzyme.
A method of treating a mammal prophylactically to prevent neoplastic development, comprising administering to said mammal a therapeutic vaccine containing venom.
A pharmaceutical formulation containing venom and/or mammalian, plant or insect anti-serum to venom for use as a therapeutic agent for the therapy of a neoplastic condition in a human or animal.
(canceled)
A pharmaceutical formulation containing one or more venoms or venom components as antigen and/or antiserum to venom.
A method according to claim 54 wherein the Phospholipase A2 enzyme is obtained from more than one species of snake and/or insect, mammal or plant.
14-18. (canceled)
20-22. (canceled)
A method of inoculation of human or animal with a combination of two or more phospholipase A2 enzyme types.
33-42. (canceled)
A method of treating neoplasm in a mammal in need of such treatment, comprising administering to said mammal a therapeutic agent comprising Phospholipase A, enzyme and/or anti-serum to Phospholipase A2 enzyme.
A method of treating a mammal prophylactically to prevent neoplastic development, comprising administering to said mammal a therapeutic vaccine containing Phospholipase A2 enzyme.
A pharmaceutical formulation comprising anti-serum to mammalian, plant or insect PLA2 enzyme.
A pharmaceutical formulation comprising mammalian, plant or insect PLA2 enzyme and/or anti-serum to mammalian, plant or insect PLA2 enzyme for use as a therapeutic agent for the therapy of a neoplastic condition in a human or animal.
A pharmaceutical formulation containing venom and/or mammalian plant or insect anti-serum to venom for use as a therapeutic agent for treating a mammal prophylactically to prevent neoplastic development.
A pharmaceutical formulation containing mammalian, plant or insect PLA2 enzyme and/or anti-serum to mammalian, plant or insect PLA2 enzyme for use as a therapeutic agent for treating a mammal prophylactically to prevent neoplastic development.
Dependencies are inferred from the claim text.